Protalix investing
Webb10 feb. 2024 · Investing Groups Leader Follow Summary Shares of plant-derived enzyme therapy concern Protalix BioTherapeutics, Inc. have rallied after its Fabry disease asset PLX-102 received a PDUFA date of...
Protalix investing
Did you know?
WebbProtalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. Webb31 mars 2024 · Of the 23 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Psagot Investment House Ltd. ($2.63M), Morgan Stanley ($1.86M), DAFNA Capital Management LLC ($1.20M), Meitav Dash Investments Ltd. …
WebbFå omedelbar tillgång till ett gratis live streamade Protalix Biotherapeutics Inc diagram. Webb11 okt. 2024 · Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner.
WebbProtalix Biotherapeutics stock was originally listed at a price of $850.00 in May 15, 1998. If you had invested in Protalix Biotherapeutics stock at $850.00, your return over the last 24 years would have been -99.75%, for an annualized return of -22.13% (not including any dividends or dividend reinvestments). Webb21 dec. 2024 · Protalix BioTherapeutics, Inc. Dec 21, 2024, 16:30 ET. The Company's Common Stock will continue to trade on the NYSE American. CARMIEL, Israel, Dec. 21, 2024 /PRNewswire/ -- Protalix ...
Webb21 mars 2024 · This table contains core financial ratios such as Price-to-Earnings , Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Protalix Biotherapeutics Inc's latest ...
WebbInvesting.com användarnas resultattavla för Protalix Biotherapeutics Inc aktien. clinipath pathology north perthWebbProtalix 2.100 +0.080 +3.96%. General. Chart. News & Analysis. Financials. Technical. Forum. Technical Analysis. Candlestick Patterns. bobby johnson giants wrWebbProtalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx ® plant cell-based expression system … bobby johnson actor bad educationWebbThis page contains information on users’ sentiments for the Protalix Biotherapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed … clinipath pathology pay your accountWebbProtalix Biotherapeutics Inc (PLX) NYSE Aggiungere uno strumento a: 2,210 + 0,070 ( + 3,27 %) 06/04 - Chiuso. Valuta in USD ( Responsabilità) After Hours 2,240 + 0,030 ( + 1,357 %) 07/04 - Dati... bobby johnson nflWebbFå detaljerad information om utdelningsdatum och utdelningsmeddelanden för Protalix. bobby johnson endocrinologist huntsvilleWebb12 apr. 2024 · By Hasnain Raza. April 12, 2024. Protalix BioTherapeutics Inc. (PLX) currently has a stock price of $2.50. The stock saw a sharp increase in the last trading session, hitting a high of $2.35 after opening at $2.30. The lowest recorded price for the day was $2.27 before it closed at $2.35. bobby johnson harlem